Skip navigation
Title: 

INFORMATION TECHNOLOGY INVESTMENT AND PRICE RECOVERY EFFECTS IN INTERNATIONAL BANKING

Authors: Duliba, Katherine A.
Kauffman, Robert J.
Keywords: Business value of IT;financial services;IT investment;international banking;productivity;price recovery;risk management
Issue Date: 8-Jul-1996
Publisher: Stern School of Business, New York University
Series/Report no.: IS-96-08
Abstract: Finns invest in information technology (IT) to create various kinds of leverage on firm profitability and performance. However, IT researchers have concentrated their efforts on the productivity impacts of technology, at the employee, process, firm, industry, and economy levels of analysis, to the exclusion of other business value impacts. Not captured by productivity metrics are the significant benefits that may accrue to the firm as product quality improves, managerial assessment of risk is enhanced, time to market and other cycle time reductions are made, and new ways to control firm input and output prices become available to management. These kinds of impacts reflect price recovery improvements - the ratio of the prices of a firm's outputs (of goods and services) to the prices of the inputs it consumes in production - and they are rarely measured or understood in a systematic way. In this paper, we argue that it is appropriate to reconsider the current measurement and research agenda that aims to discover and document the payoffs that accrue from corporate investments in IT. We illustrate the extent to which IT investment may be motivated by management's understanding of the potential price recovery payoffs (even if they fail to carefully measure or report them) in the context of trading and treasury operations in international banking. We find that price recovery captures a previously unmeasured dimension of the business value of IT.
URI: http://hdl.handle.net/2451/14197
Appears in Collections:IOMS: Information Systems Working Papers

Files in This Item:
File Description SizeFormat 
IS-96-08.pdf6.39 MBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.